Truqap is usually a kinase inhibitor that works by blocking pathways that aid the cancer cells endure and develop, so decreases cancer development. Truqap is from a category of medicines identified as an AKT inhibitor. Truqap obtained FDA approval on November seventeen, 2023, just after beneficial outcomes through the CAPItello-291 https://maynardv000ite3.techionblog.com/profile